down arrow

American Well Corp.

  • Market Cap: Micro Cap
  • Industry: Computers - Software & Consulting
  • ISIN: US03044L1052
USD
4.12
0.04 (0.98%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

4.074.17

52 Week

3.7312.95
Valuation
Technical
Day's Volume

CASH

11.1 k

Shareholding (Mar 2025)

FII

14.14%

Held by 78 FIIs

DII

65.4%

Held by 17 DIIs

Promoter

4.31%

How big is American Well Corp.?

22-Jun-2025

As of Jun 18, American Well Corp. has a market capitalization of 105.77 million and reported net sales of 261.68 million with a net loss of 157.55 million over the latest four quarters.

As of Jun 18, American Well Corp. has a market capitalization of 105.77 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 261.68 million for the latest four quarters, while the net profit for the same period was a loss of 157.55 million.<BR><BR>As of Dec 24, the shareholder's funds were 304.77 million, and the total assets amounted to 435.97 million.

Read More

What does American Well Corp. do?

22-Jun-2025

American Well Corporation is a telehealth company that provides digital healthcare solutions, with recent net sales of $67 million and a market cap of $105.77 million. It is currently operating at a loss, with a net profit of -$18 million.

Overview: <BR>American Well Corporation is a telehealth company enabling digital delivery of care for the healthcare sector, operating within the Computers - Software & Consulting industry and classified as a micro-cap.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 67 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -18 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 105.77 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.74 <BR>Return on Equity: -48.25% <BR>Price to Book: 0.36<BR><BR>Contact Details: <BR>Address: 75 STATE STREET, 26TH FLOOR, BOSTON MA : 02109 <BR>Tel: 1 617 2053500 <BR>Fax: 1 302 6365454 <BR>Website: https://business.amwell.com/

Read More

Who are in the management team of American Well Corp.?

22-Jun-2025

As of March 2022, the management team of American Well Corp. includes Ido Schoenberg as Chairman and CEO, Roy Schoenberg as President and CEO, and Deborah Jackson as an Independent Director.

As of March 2022, the management team of American Well Corp. includes Mr. Ido Schoenberg, who serves as the Chairman of the Board and Chief Executive Officer, and Dr. Roy Schoenberg, who is the President, Chief Executive Officer, and a Director. Additionally, Ms. Deborah Jackson is an Independent Director on the board.

Read More

Is American Well Corp. technically bullish or bearish?

20-Sep-2025

As of September 10, 2025, American Well Corp. is in a bearish trend with weak strength indicators, having significantly underperformed the S&P 500 with a 1-year return of -33.37% and a 5-year return of -98.58%.

As of 10 September 2025, the technical trend for American Well Corp. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the weekly MACD, Bollinger Bands, KST, and moving averages all signaling bearish trends. The Dow Theory also reflects a mildly bearish outlook. The stock has underperformed significantly compared to the S&P 500 across multiple periods, with a 1-year return of -33.37% versus the S&P's 17.14%, and a staggering 5-year return of -98.58% compared to the S&P's 96.61%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate 3.92% of over the last 5 years

 
2

The company has declared Positive results for the last 4 consecutive quarters

3

Risky - Negative EBITDA

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Computers - Software & Consulting

stock-summary
Market cap

USD 112 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.76

stock-summary
Return on Equity

-40.18%

stock-summary
Price to Book

0.40

Revenue and Profits:
Net Sales:
71 Million
(Quarterly Results - Jun 2025)
Net Profit:
-20 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-38.69%
0%
-38.69%
6 Months
-40.46%
0%
-40.46%
1 Year
-58.17%
0%
-58.17%
2 Years
-84.51%
0%
-84.51%
3 Years
7.57%
0%
7.57%
4 Years
-96.61%
0%
-96.61%
5 Years
-99.26%
0%
-99.26%

American Well Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is American Well Corp. technically bullish or bearish?

As of 10 September 2025, the technical trend for American Well Corp. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the weekly MACD, Bollinger Bands, KST, and moving averages all signaling bearish trends. The Dow Theory also reflects a mildly bearish outlook. The stock has underperformed significantly compared to the S&P 500 across multiple periods, with a 1-year return of -33.37% versus the S&P's 17.14%, and a staggering 5-year return of -98.58% compared to the S&P's 96.61%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.95%
EBIT Growth (5y)
3.92%
EBIT to Interest (avg)
-222.92
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
0.66
Tax Ratio
1.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
62.40%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.37
EV to EBIT
0.69
EV to EBITDA
0.88
EV to Capital Employed
-1.44
EV to Sales
-0.42
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-48.25%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 32 Schemes (16.15%)

Foreign Institutions

Held by 78 Foreign Institutions (14.14%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 12.90% vs 0.64% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 61.46% vs 45.88% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "70.90",
          "val2": "62.80",
          "chgp": "12.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.40",
          "val2": "-38.80",
          "chgp": "75.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.50",
          "val2": "-5.30",
          "chgp": "52.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-19.50",
          "val2": "-50.60",
          "chgp": "61.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-251.60%",
          "val2": "-749.80%",
          "chgp": "49.82%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.78% vs -6.57% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 68.70% vs -149.61% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "254.40",
          "val2": "259.00",
          "chgp": "-1.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-163.20",
          "val2": "-219.30",
          "chgp": "25.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-20.90",
          "val2": "-440.90",
          "chgp": "95.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-212.60",
          "val2": "-679.20",
          "chgp": "68.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-773.10%",
          "val2": "-969.90%",
          "chgp": "19.68%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
70.90
62.80
12.90%
Operating Profit (PBDIT) excl Other Income
-9.40
-38.80
75.77%
Interest
0.00
0.00
Exceptional Items
-2.50
-5.30
52.83%
Consolidate Net Profit
-19.50
-50.60
61.46%
Operating Profit Margin (Excl OI)
-251.60%
-749.80%
49.82%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 12.90% vs 0.64% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 61.46% vs 45.88% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
254.40
259.00
-1.78%
Operating Profit (PBDIT) excl Other Income
-163.20
-219.30
25.58%
Interest
0.00
0.00
Exceptional Items
-20.90
-440.90
95.26%
Consolidate Net Profit
-212.60
-679.20
68.70%
Operating Profit Margin (Excl OI)
-773.10%
-969.90%
19.68%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -1.78% vs -6.57% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 68.70% vs -149.61% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About American Well Corp. stock-summary
stock-summary
American Well Corp.
Computers - Software & Consulting
American Well Corporation is a telehealth company enabling digital delivery of care for the healthcare sector. The Amwell Platform is a digital care delivery solution that equips its health system and health plan, including government, clients with the tools to enable new models of care for their patients and members. Its technology embeds with its clients’ existing offerings and clinical workflows, spanning the continuum of care and enabling care delivery across a range of clinical, retail, school and home settings. The Amwell Platform consists of the home line, provider-to-patient telehealth interactions, typically in the home, and the hospital line, supporting provider-to-provider telehealth interactions, or provider-to-patient, typically in an inpatient or ambulatory setting. The Company offers a range of management software, clinical workflows, Carepoint hardware and system integrations to deliver care across various modalities, including video, phone and secure messaging.
Company Coordinates stock-summary
Company Details
75 STATE STREET, 26TH FLOOR , BOSTON MA : 02109
stock-summary
Tel: 1 617 2053500
stock-summary
https://business.amwell.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."